MENU
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Esperion Therapeutics (ESPR) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 4.27% to -14 cents per share on February 27

Esperion Therapeutics ESPR Stock Earnings Reports
Q4'24
Est.
$-0.14
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.29
Q4'23
Missed
by $0.03
The last earnings report on November 07 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 769.52K shares outstanding, the current market capitalization sits at 495.94M.
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com